Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Aronora opens phase II study of AB-002 in end-stage renal disease patients on chronic hemodialysis

Aug. 1, 2019

Roystonea regia lipid extract reduces lower urinary tract symptoms in men with BPH

July 26, 2019

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

July 24, 2019

BioMarin Pharmaceutical identifies hydroxyacid oxidase 1 inhibitors

July 24, 2019

DiaMedica reports phase Ib interim data on DM-199 in chronic kidney disease

June 20, 2019

Arch Biopartners initiates phase I study of Metablok

June 20, 2019

Corvidia opens phase II study of ziltivekimab to reduce inflammation in chronic renal disease

June 14, 2019

RNA triad prevents dialysis-induced fibrosis

June 14, 2019

Increased CCL14 expression linked to chronic kidney disease

June 13, 2019

Positive topline results presented for phase II study of Gazyva in lupus nephritis

June 11, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...